Mastodawn

The UK's Pathways trial for puberty blockers has been paused. The regulator, MHRA, has safety concerns, especially about the age limit for participants.

#PubertyBlockers, #UKTrial, #MHRA, #YouthHealth, #GenderIncongruence

https://newsletter.tf/uk-puberty-blocker-trial-paused-due-to-mhra-safety-concerns/

UK Puberty Blocker Trial Paused After Regulator Raises Safety Concerns for Young People

UK's Pathways trial for puberty blockers paused by MHRA due to safety concerns. Discusses age limits and future of the trial for young people.